AUSTIN -- Dose escalation of ustekinumab (Stelara) should be considered for patients with Crohn's disease and manifestations of the condition, a researcher said here. Among 38 adults with Crohn's ...
Please provide your email address to receive an email when new articles are posted on . AUSTIN, Texas — Real-world dose escalation of Stelara was safe and effective in patients with perianal Crohn’s ...
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets ...
On May 22, 2025, the FDA approved Bio-Thera Solutions and Hikma Pharmaceuticals’ ustekinumab biosimilar, STARJEMZA® (ustekinumab-hmny) injection, referencing Janssen’s STELARA® (ustekinumab) injection ...
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Alvotech (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results